|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.337 SEK | +0.90% |
|
+4.01% | +77.56% |
| 06-11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
| 05-27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
Note: interview in Swedish
Attachments
Disclaimer
Acarix AB published this content on 21 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 January 2022 15:52:02 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +77.56% | 31.34M | |
| -34.99% | 14.7B | |
| -52.73% | 2.33B | |
| +24.29% | 1.96B | |
| -8.30% | 1.52B | |
| +21.24% | 1.24B | |
| -21.39% | 904M | |
| -34.32% | 750M | |
| +1.33% | 784M | |
| -28.73% | 597M |
ACARIX AB 
